» Articles » PMID: 22863739

Mesenchymal Stem Cells in Tumor Development: Emerging Roles and Concepts

Overview
Journal Cell Adh Migr
Specialty Cell Biology
Date 2012 Aug 7
PMID 22863739
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) are multipotent progenitor cells that participate in the structural and functional maintenance of connective tissues under normal homeostasis. They also act as trophic mediators during tissue repair, generating bioactive molecules that help in tissue regeneration following injury. MSCs serve comparable roles in cases of malignancy and are becoming increasingly appreciated as critical components of the tumor microenvironment. MSCs home to developing tumors with great affinity, where they exacerbate cancer cell proliferation, motility, invasion and metastasis, foster angiogenesis, promote tumor desmoplasia and suppress anti-tumor immune responses. These multifaceted roles emerge as a product of reciprocal interactions occurring between MSCs and cancer cells and serve to alter the tumor milieu, setting into motion a dynamic co-evolution of both tumor and stromal tissues that favors tumor progression. Here, we summarize our current knowledge about the involvement of MSCs in cancer pathogenesis and review accumulating evidence that have placed them at the center of the pro-malignant tumor stroma.

Citing Articles

The protective effect of endurance running against the pro-invasive effects of ageing in breast cancer cells and mesenchymal stem cells .

Brown M, Nickels M, Akam E, Morris M In Vitro Model. 2025; 2(6):263-280.

PMID: 39872498 PMC: 11756502. DOI: 10.1007/s44164-023-00055-y.


Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists.

Minev T, Balbuena S, Gill J, Marincola F, Kesari S, Lin F Oncotarget. 2024; 15:793-805.

PMID: 39576660 PMC: 11584032. DOI: 10.18632/oncotarget.28672.


The role of mesenchymal cells in cholangiocarcinoma.

Sueca-Comes M, Rusu E, Ashworth J, Collier P, Probert C, Ritchie A Dis Model Mech. 2024; 17(12).

PMID: 39492622 PMC: 11655028. DOI: 10.1242/dmm.050716.


Image-Guided Mesenchymal Stem Cell Sodium Iodide Symporter (NIS) Radionuclide Therapy for Glioblastoma.

Shah S, Lucke-Wold B Cancers (Basel). 2024; 16(16).

PMID: 39199662 PMC: 11352884. DOI: 10.3390/cancers16162892.


Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer-Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies.

Starska-Kowarska K Cells. 2024; 13(15.

PMID: 39120301 PMC: 11311692. DOI: 10.3390/cells13151270.


References
1.
Lim P, Bliss S, Patel S, Taborga M, Dave M, Gregory L . Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res. 2011; 71(5):1550-60. DOI: 10.1158/0008-5472.CAN-10-2372. View

2.
Bruder S, Fink D, Caplan A . Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994; 56(3):283-94. PMC: 7166813. DOI: 10.1002/jcb.240560303. View

3.
Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F . Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008; 15(10):730-8. DOI: 10.1038/gt.2008.39. View

4.
Erices A, Conget P, Minguell J . Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1):235-42. DOI: 10.1046/j.1365-2141.2000.01986.x. View

5.
Zhang H, Ning H, Banie L, Wang G, Lin G, Lue T . Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties. Biochem Biophys Res Commun. 2010; 402(3):560-4. PMC: 3530412. DOI: 10.1016/j.bbrc.2010.10.090. View